If you or someone close to you has been diagnosed with early-stage breast cancer, join us for a two-part webinar series on understanding the risk of breast cancer recurrence, available therapies that can help reduce the risk of recurrence, and how to manage side effects.
During each webinar, there will be time for you to ask questions. Family, friends, and healthcare providers are welcome to participate.
Part I: Understanding risk of recurrence: Tests and treatments
Thursday, October 26 | 7:00 - 8:15 p.m. (ET)
In this session, Virginia Borges MD, MMSc will discuss:
- Different levels of breast cancer recurrence risk
- Unique needs of individuals living with a high risk of recurrence
- Tests used to assess risk, including the latest in testing innovations
- Treatments that can help reduce the risk of recurrence
Dr. Borges will also share tips on lifestyle modifications to support health and wellbeing after a breast cancer diagnosis, and how to talk to your doctor about your individual risk of recurrence.
Virginia F. Borges, MD, MMSc
Deputy Head, Division of Medical Oncology Director, Breast Cancer Research Program & Young Women’s Breast Cancer Translational Program at the University of Colorado Anschutz Medical Campus
Virginia F. Borges, MD, MMSc, founded and directs the Young Women’s Breast Cancer Clinic at the University of Colorado Comprehensive Cancer Center. The YWBCC of Colorado covers the unique issues of young women at diagnosis, through treatment, and beyond. She is on the Medical Advisory Board for Living Beyond Breast Cancer.Read more
Thank you to our Part I sponsors
Part II: Managing treatment side effects of anti-estrogen therapies
Thursday, November 2| 7:00 - 8:15 p.m. (ET)
Treatments that reduce the risk of breast cancer recurrence can also cause side effects. Some common side effects can include menopausal symptoms such as hot flashes, bone loss, joint pain, and sexual side effects. There can also be concerns about heart health.
In this session, Evelyn Robles-Rodriguez DNP, APN, AOCN will discuss side effects caused by anti-estrogen therapies such as tamoxifen, aromatase inhibitors, and ovarian suppression, plus ways to manage them.
She will be joined by a panel of people who’ve taken some of these treatments, and they’ll share their personal experiences with managing side effects.
Evelyn Robles-Rodriguez DNP, APN, AOCN
Director of Outreach, Prevention, and Survivorship, MD Anderson Cancer Center at Cooper
Evelyn Robles-Rodriguez, DNP, APN, AOCN serves as the director for outreach, prevention, and survivorship. Her research interests are in breast cancer, solid tumors, cancer screening and prevention, women's health, and cancer survivorship.
She is bilingual in English and Spanish and is committed to the cancer education of the lay and professional community. She is on the Medical Advisory Board for Living Beyond Breast Cancer.Read more
Thank you to our Part II sponsors
Sign up to find out when registration opens, and to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.